Psoriasis Scalp Treatment Liquid
FDA Label NDC 83004-026

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Rida Llc for the product Psoriasis Scalp Treatment (NDC 83004-026). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, directions, other information, inactive ingredients, product label, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Active Ingredient

Salicylic Acid 3%

Purpose

Minimizes scalp irritation and itching

Uses

  • Specifically formulated for the treatment of scalp fungal infections.
  • Effective against ringworm on the scalp.
  • Provides relief from symptoms associated with folliculitis on the scalp.
  • Alleviates discomfort caused by lichen planus affecting the scalp.

Warnings

  • For external use only.
  • Do not apply to broken skin or open wounds.
  • Discontinue use if irritation or rash occurs.
  • Keep out of reach of children.
  • If pregnant or breastfeeding, consult a healthcare professional before use.

Directions

  • Shake well before use. 
  • Apply the Folliculitis Scalp Spray to the affected area 2–3 times daily. 
  • Avoid contact with eyes and mucous membranes. 
  • If symptoms persist or worsen, consult a healthcare provider.

Other Information

  • Store in a cool, dry place. Protect from direct sunlight.

Inactive Ingredients

Aqua (Water), Trehalose, Benzalkonium Chloride, Mirtazapine, Hexamidine, Sodium Hyaluronate, Salvia Miltiorrhiza Extract, Ginkgo Biloba Extract, Bacillus Subtilis Ferment, Coptis Chinensis Extract, 1,2-Hexanediol, Hydroxypropyl Guar, Saponins, Apple Cider Vinegar

Product Label

Image Description (Image 14)

Image Description (Image 14)

* Please review the disclaimer below.